Cormorant Asset Management, LP - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 30 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$10,050,000
+34.2%
500,000
+4.1%
1.46%
+44.5%
Q4 2016$7,491,000
+19.5%
480,5010.0%1.01%
+46.0%
Q3 2016$6,271,000
+90.5%
480,5010.0%0.69%
+48.2%
Q2 2016$3,291,000
-26.7%
480,501
+1.2%
0.47%
-30.9%
Q1 2016$4,489,000
+25.0%
475,035
+33.2%
0.68%
+57.2%
Q4 2015$3,591,000
-29.6%
356,6000.0%0.43%
-47.2%
Q3 2015$5,103,000356,6000.82%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders